Literature DB >> 9950950

VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule.

M Burnatowska-Hledin1, I B Lazdins, L Listenberger, P Zhao, A Sharangpani, V Folta, B Card.   

Abstract

The vasopressin-activated calcium-mobilizing (VACM-1) protein is a novel arginine vasopressin (AVP) receptor that shares sequence homology with a cullin multigene family but not with the AVP receptors. To characterize the VACM-1 receptor, we examined its tissue-specific expression using Northern blot, RT-PCR, and immunostaining analyses. Northern blot hybridization identified a 6. 4-kb cRNA species that was expressed in the rabbit kidney medulla, brain, heart, and ovaries. In human tissue, VACM-1 mRNA is a larger (7.5 kb) cRNA found in the kidney, brain, heart, placenta, and skeletal muscle. VACM-1-specific RT-PCR products were detected in mRNA from rabbit kidney medulla, brain, heart, and mesenteric arteries. No expression of VACM-1 could be detected in rabbit aorta, gastrointestinal tract, or liver. Coimmunostaining with anti-VACM-1 antibodies (Ab) and a specific vascular endothelial cell marker, CD31 monoclonal Ab, localized VACM-1 expression to the vasculature in specific tissues. We identified the kidney cells expressing VACM-1 receptor by coimmunostaining with the following monoclonal Ab, which recognize epitopes in specific segments of the nephron: rct-30 Ab, reactive against the cortical and medullary collecting tubule (CT) cells; mr-omct Ab, reactive against the mitochondria-rich cells of the outer medullary CT; and an Ab specific against the loop of Henle segment. These studies indicated that the VACM-1 receptor is expressed only in the medullary CT. Kidney coimmunostaining with anti-VACM-1 and CD31 Ab identified VACM-1-receptor expression in glomeruli and medullary vascular bundles. These results demonstrate that the novel VACM-1 receptor, expressed in many organs, is localized to the endothelial cells. In the kidney, it is also expressed in the medullary CT cells. Thus VACM-1 may be involved in the regulation of endothelial permeability and water transport in the CT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950950     DOI: 10.1152/ajprenal.1999.276.2.F199

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.

Authors:  E Querido; P Blanchette; Q Yan; T Kamura; M Morrison; D Boivin; W G Kaelin; R C Conaway; J W Conaway; P E Branton
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

2.  Analysis of the Cullin binding sites of the E4orf6 proteins of human adenovirus E3 ubiquitin ligases.

Authors:  Timra Gilson; Chi Ying Cheng; Woosuk Steve Hur; Paola Blanchette; Philip E Branton
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 3.  The functions and properties of cullin-5, a potential therapeutic target for cancers.

Authors:  Feng Gao; Yimin Fan; Bolun Zhou; Weihua Guo; Xingjun Jiang; Jing Shi; Caiping Ren
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

4.  Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect.

Authors:  Shirley E Bradley; Alyssa E Johnson; Isabelle P Le; Elizabeth Oosterhouse; Michael P Hledin; Gabriel A Marquez; Maria Burnatowska-Hledin
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

5.  Deep Characterization of Circular RNAs from Human Cardiovascular Cell Models and Cardiac Tissue.

Authors:  Tobias Jakobi; Dominik Siede; Jessica Eschenbach; Andreas W Heumüller; Martin Busch; Rouven Nietsch; Benjamin Meder; Patrick Most; Stefanie Dimmeler; Johannes Backs; Hugo A Katus; Christoph Dieterich
Journal:  Cells       Date:  2020-07-04       Impact factor: 6.600

6.  Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues.

Authors:  Michael J Fay; Kenneth A Longo; George A Karathanasis; David M Shope; Craig J Mandernach; Jason R Leong; Alfred Hicks; Kenneth Pherson; Amyna Husain
Journal:  Mol Cancer       Date:  2003-11-25       Impact factor: 27.401

Review 7.  The role of cullin 5-containing ubiquitin ligases.

Authors:  Fumihiko Okumura; Akiko Joo-Okumura; Kunio Nakatsukasa; Takumi Kamura
Journal:  Cell Div       Date:  2016-03-09       Impact factor: 5.130

8.  CUL5 is required for thalidomide-dependent inhibition of cellular proliferation.

Authors:  Bryan Kunkler; Daniel Salamango; Zachary J DeBruine; Caitlin Ploch; Shirley Dean; David Grossens; Michael P Hledin; Gabriel A Marquez; Julie Madden; Abigayle Schnell; Michael Short; Maria A Burnatowska-Hledin
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.